Pharmaust Limited (AU:NUZ) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Neurizon Therapeutics Limited, a biotech firm focused on neurodegenerative disease treatments, has updated its Securities Trading Policy, as announced on the ASX. The company is actively advancing its lead drug candidate, NUZ-001, which targets ALS, the most prevalent form of motor neurone disease. This update aligns with Neurizon’s commitment to accelerating treatment access and exploring broader applications for its drug.
For further insights into AU:NUZ stock, check out TipRanks’ Stock Analysis page.